TMRW Life Sciences
- Industry
- Fertility Technology
- Founded Year
- 2018
- Headquarters
- New York, NY
- Employee Count
- 106
Key People
- Louis Villalba - Chief Executive Officer
- Alan Murray - Founder
- Joshua Abram - Founder & Co-CEO
- Jeffrey Port - Founder & Chief Medical Officer
- Brian E Miller - Senior Vice President Of Sales
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced entrepreneurs with successful backgrounds in MedTech and related fields.
The founders and executives have a proven track record in MedTech and technology sectors, bringing valuable expertise to TMRW Life Sciences.
- Clinical Need
-
Aspect: Very Strong
Summary: The company's solutions address critical needs in fertility treatment, enhancing safety and efficiency.
TMRW's technology modernizes egg and embryo storage, addressing longstanding challenges in IVF procedures.
- Competition
-
Aspect: First mover
Summary: TMRW is pioneering automated cryo-management in fertility, with limited direct competition.
As the first to market with this technology, TMRW has the advantage of setting industry standards but may face challenges in market adoption and educating stakeholders.
- Technical Challenge
-
Aspect: Predictable
Summary: The technology involves complex systems but is based on established principles, making challenges manageable.
While integrating robotics and digital tracking is complex, the underlying technologies are mature, reducing unforeseen risks.
- Patent
-
Aspect: Strong
Summary: TMRW has a robust patent portfolio, including recent acquisitions to expand its offerings.
The acquisition of Cryogatt's patent portfolio strengthens TMRW's intellectual property, supporting its market position.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors, indicating strong financial health.
Investments from firms like 5AM Ventures and GV provide the capital needed for expansion and innovation.
- Regulatory
-
Aspect: 510k/PMA
Summary: TMRW's products have received necessary regulatory clearances, facilitating market entry.
FDA clearance and CE marking demonstrate compliance with regulatory standards, enhancing credibility and market access.
Opportunity Rollup
- Odds of Success
- 3.3
- Peak Market Share
- 3.9
- Segment CAGR
- 4.6%
- Market Segment
- Fertility Technology
- Market Sub Segment
- Automated Cryo-Management Systems
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.20 |
| 2 | 0.58 |
| 3 | 1.36 |
| 4 | 2.73 |
| 5 | 3.90 |
Key Takeaway
TMRW Life Sciences is well-positioned to capitalize on the growing fertility technology market with its innovative solutions and experienced team.